TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
EDSA

Edesa Biotech Inc

Healthcare · Biotechnology

4.00$ -4.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

Edesa Biotech Inc (EDSA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -7.3 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EDSA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-4.3 -4.4 -4.5 -4.7 -4.6 -4.8 -5.0 -14 -12 -6.6 -4.9 -7.3
0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.1
1.0 0.3 0.3 0.1 0.2 0.0 0.6 3.2 2.3 1.2 0.5 0.7
– – – 0.1 0.1 0.0 0.6 3.2 2.3 – – –
0.2 -0.5 0.0 0.2 0.0 -2.1 0.7 -3.6 2.9 0.3 0.6 -1.0
0.3 0.3 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-0.7 0.1 0.6 1.7 -4.5 6.4 0.0 0.0 0.0 – – –
– 0.1 7.6 – 9.2 – – – – – – –
– – – 0.4 0.0 0.0 0.0 0.0 – 0.0 0.0 0.0
11 0.1 7.3 0.0 8.8 7.1 7.1 14 12 4.8 0.6 17
5.6 -4.8 3.5 -2.8 -0.3 1.7 2.2 0.6 -0.7 -1.7 -4.3 9.8
-4.5 -4.7 -4.9 -5.0 -5.0 -4.9 -5.0 -14 -12 -6.6 -4.9 -7.3

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?